【泰宗生物科技股份有限公司】2026年Q1 EPS -0.45元
NQ 評分
0/100
N1 內容完整性
0
AI 摘要（NQ 加工版）
Taizong Biotech Co., Ltd. announced its Q1 2026 financial results, reporting a net loss with an EPS of -0.45 TWD. The company generated 173 million TWD in revenue and a net profit of -26 million TWD, indicating a challenging quarter for the biotechnology and medical company.